Key terms
About ADVM
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADVM news
Mar 27
9:50pm ET
Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)
Mar 25
10:30pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 21
5:26pm ET
Adverum Biotechnologies files $200M mixed securities shelf
Mar 21
2:46am ET
Positive Outlook for Adverum Biotechnologies with Upcoming Ixo-vec Milestones and Strong Financial Position
Mar 20
7:50pm ET
Adverum Biotechnologies trading halted, news pending
Mar 20
2:00am ET
Brexit Uncertainty: Navigating New Risks and Regulatory Hurdles for Adverum Biotechnologies
Mar 19
7:20am ET
Adverum Biotechnologies price target lowered to $2 from $3 at RBC Capital
Mar 19
6:45am ET
Adverum Biotechnologies (ADVM) Initiated with a Hold at RBC Capital
Mar 18
5:55pm ET
Adverum Biotechnologies (ADVM) Receives a Buy from TD Cowen
Mar 18
4:13pm ET
Adverum Biotechnologies reports Q4 EPS (23c), consensus (34c)
Mar 04
4:42pm ET
Adverum Biotechnologies files to sell 106.48M shares of common stock for holders
Feb 09
4:20am ET
Adverum’s Ixoberogene Soroparvovec Shows Promise in LUNA Trial
Feb 08
11:40am ET
Biotech Alert: Searches spiking for these stocks today
Feb 08
7:05am ET
Adverum Biotechnologies announces efficacy, safety data from LUNA Phase 2 trial
Feb 07
11:01am ET
Biotech Alert: Searches spiking for these stocks today
Feb 07
5:07am ET
Adverum Biotechnologies Awaits Court Decision on Settlement
Feb 06
6:38am ET
Adverum Biotechnologies price target raised to $4 from $2 at Mizuho
Feb 06
5:03am ET
Adverum Biotechnologies Executes Private Equity Placement
Feb 06
5:02am ET
Adverum Biotechnologies Secures $127.8M in Private Placement
Feb 05
10:51am ET
Biotech Alert: Searches spiking for these stocks today
Feb 05
7:47am ET
Adverum Biotechnologies to sell 106.25M shares at $1.20 in private placement
Feb 05
4:50am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW)
No recent press releases are available for ADVM
ADVM Financials
Key terms
Ad Feedback
ADVM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADVM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range